Cancer Drug Discovery and Preclinical Development Summit
Optimising early-stage research for oncology therapeutics
Dr Tim Hammonds, CRT’s Discovery Laboratories’ deputy director of discovery, will be giving the opening address at the Cancer Drug Discovery and Preclinical Development Summit.
Tim will be exploring how to successfully build and prosecute industry-academic alliances in oncology, drawing on CRT-DL’s innovative alliance model which brings together the best minds from industry and academic to work around themed areas of cancer biology.
Successfully Building and Prosecuting Industry-Academia Alliances in Oncology
- Why we need alliances to further oncology discovery
- Alliance models
- Running a successful alliance